EG25097A - Piprazinyl and diazapanyl benzamides and benzthioamides. - Google Patents

Piprazinyl and diazapanyl benzamides and benzthioamides.

Info

Publication number: EG25097A
Authority: EG; Egypt
Prior art keywords: benzthioamides; piprazinyl; diazapanyl; benzamides; diazapanyl benzamides
Prior art date: 2002-10-23

Application number

Other languages

English (en)

Inventor

Richard L Apodaca

Jill A Jablonowski

Kiev S Ly

Chandravadan R Shah

Devin M Swanson

Wei Xiao

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-23

Filing date

2005-04-20

Publication date

2011-08-17

2005-04-20 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2011-08-17 Application granted granted Critical

2011-08-17 Publication of EG25097A publication Critical patent/EG25097A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0465—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K51/047—Benzodiazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Optics & Photonics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Pathology (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Obesity (AREA)

EGNA2005000151 2002-10-23 2005-04-20 Piprazinyl and diazapanyl benzamides and benzthioamides. EG25097A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US42049502P	2002-10-23	2002-10-23
PCT/US2003/033343 WO2004037801A1 (en)	2002-10-23	2003-10-21	Piperazinyl and diazapanyl benzamides and benzthioamides

Publications (1)

Publication Number	Publication Date
EG25097A true EG25097A (en)	2011-08-17

Family

ID=32176579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EGNA2005000151 EG25097A (en)	2002-10-23	2005-04-20	Piprazinyl and diazapanyl benzamides and benzthioamides.

Country Status (32)

Country	Link
US (2)	US7414047B2 (sr)
EP (1)	EP1558595B1 (sr)
JP (1)	JP4596918B2 (sr)
KR (1)	KR101067732B1 (sr)
CN (1)	CN100558718C (sr)
AR (1)	AR041697A1 (sr)
AT (1)	ATE449766T1 (sr)
AU (1)	AU2003301552B2 (sr)
BR (1)	BRPI0315644B8 (sr)
CA (1)	CA2504269C (sr)
CR (1)	CR7807A (sr)
CY (1)	CY1109924T1 (sr)
DE (1)	DE60330269D1 (sr)
DK (1)	DK1558595T3 (sr)
EA (1)	EA009860B1 (sr)
EG (1)	EG25097A (sr)
ES (1)	ES2335584T3 (sr)
HR (1)	HRP20050352B1 (sr)
IL (1)	IL168207A (sr)
ME (1)	ME00334B (sr)
MX (2)	MX339074B (sr)
MY (1)	MY140886A (sr)
NO (1)	NO330741B1 (sr)
NZ (2)	NZ576432A (sr)
PL (1)	PL215454B1 (sr)
PT (1)	PT1558595E (sr)
RS (1)	RS51681B (sr)
SI (1)	SI1558595T1 (sr)
TW (1)	TWI352594B (sr)
UA (1)	UA80573C2 (sr)
WO (1)	WO2004037801A1 (sr)
ZA (1)	ZA200504067B (sr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE449766T1 (de)	2002-10-23	2009-12-15	Janssen Pharmaceutica Nv	Piperazinyl- und diazapanylbenzamide und- benzothioamide
GB0324159D0 (en) *	2003-10-15	2003-11-19	Glaxo Group Ltd	Novel compounds
JP2007531753A (ja) *	2004-03-31	2007-11-08	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	非イミダゾール系複素環式化合物
MXPA06011410A (es)	2004-03-31	2007-04-20	Johnson & Johnson	Compuestos heterociclicos sin imidazol como moduladores de receptor de histamina h3.
KR101336106B1 (ko) *	2005-09-16	2013-12-05	얀센 파마슈티카 엔.브이.	히스타민 ｈ3 수용체의 조절제로서 사이클로프로필 아민
DK1951699T3 (da) *	2005-10-31	2013-01-14	Janssen Pharmaceutica Nv	Fremgangsmåder til fremstilling af cyclopropylamidderivater
US7795426B2 (en) *	2005-10-31	2010-09-14	Janssen Pharmaceutica Nv	Processes for the preparation of cyclopropyl-amide derivatives
EP2404911A1 (en) *	2005-10-31	2012-01-11	Janssen Pharmaceutica NV	Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
RU2428423C2 (ru) *	2005-11-10	2011-09-10	Баниу Фармасьютикал Ко., Лтд.	Азазамещенные спиропроизводные
MX339668B (es) *	2006-05-30	2016-06-02	Janssen Pharmaceutica N V *	Compuestos de piridil amida sustituidos como moduladores del receptor h3 de la histamina.
CA2655604C (en)	2006-06-23	2016-08-09	Abbott Laboratories	Cyclopropyl amine derivatives
US9108948B2 (en)	2006-06-23	2015-08-18	Abbvie Inc.	Cyclopropyl amine derivatives
CN101511807A (zh) *	2006-06-29	2009-08-19	詹森药业有限公司	组胺h3受体的取代的苯甲酰胺调节剂
ES2620818T3 (es) *	2006-12-14	2017-06-29	Janssen Pharmaceutica N.V.	Procedimiento para la preparación de derivados de piperazinil y diazepanil benzamida
WO2009030716A1 (en) *	2007-09-06	2009-03-12	Glaxo Group Limited	Piperazine derivative having affinity for the histamine h3 receptor
AR068509A1 (es) *	2007-09-19	2009-11-18	Jerini Ag	Antagosnistas del receptor de bradiquinina b1
CN105712977B (zh)	2007-11-20	2021-06-29	詹森药业有限公司	作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物
US20100130477A1 (en) *	2008-11-25	2010-05-27	Astrazeneca Ab	Spirocyclobutyl Piperidine Derivatives
HRP20170776T1 (hr) *	2009-03-18	2017-08-11	Janssen Pharmaceutica N.V.	Postupak za pripravu modulatora histaminskog h3 receptora
US9186353B2 (en)	2009-04-27	2015-11-17	Abbvie Inc.	Treatment of osteoarthritis pain
US8853390B2 (en)	2010-09-16	2014-10-07	Abbvie Inc.	Processes for preparing 1,2-substituted cyclopropyl derivatives
RU2700595C1 (ru) *	2019-07-30	2019-09-18	Общество с ограниченной ответственностью "Кью Эм Фарма"	Производное 3,6,9-триазатрициклотетрадекана и его применение для лечения депрессии
EP4251148A1 (en)	2020-11-27	2023-10-04	Richter Gedeon Nyrt.	Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3714179A (en)	1970-09-08	1973-01-30	Searle & Co	1-alkyl-2-furfurylthioimidazoles and congeners
US3886160A (en)	1972-09-28	1975-05-27	Searle & Co	2-(2-Methyl-5-nitro-1-imidazolyl) ethyl-2-thiopseudoureas
CA1265798A (en) *	1984-12-10	1990-02-13	Motoo Mutsukado	3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JP2813747B2 (ja)	1989-05-22	1998-10-22	富士写真フイルム株式会社	画像形成法
US5030644A (en)	1989-07-31	1991-07-09	Merck & Co., Inc.	Imidazole compounds and their use as transglutaminase inhibitors
US5492891A (en)	1991-09-05	1996-02-20	Novo Nordisk A/S	Method for treatment of patients with chronic liver disease
US5569659A (en)	1991-09-11	1996-10-29	Mcneilab, Inc.	4-arylpiperazines and 4-arylpiperidines
US5217986A (en)	1992-03-26	1993-06-08	Harbor Branch Oceanographic Institution, Inc.	Anti-allergy agent
US5352707A (en) *	1992-03-26	1994-10-04	Harbor Branch Oceanographic Institution, Inc.	Method for treating airway congestion
RU2124511C1 (ru)	1993-05-14	1999-01-10	Фармасьютикал Ко., Лтд	Производные пиперазина
US5681954A (en)	1993-05-14	1997-10-28	Daiichi Pharmaceutical Co., Ltd.	Piperazine derivatives
US5464788A (en)	1994-03-24	1995-11-07	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
EP0794779A4 (en)	1994-12-22	1998-04-29	Smithkline Beecham Corp	FIBRINOGENIC RECEPTOR ANTAGONISTS
IL117149A0 (en)	1995-02-23	1996-06-18	Schering Corp	Muscarinic antagonists
US5889006A (en)	1995-02-23	1999-03-30	Schering Corporation	Muscarinic antagonists
JPH09294056A (ja) *	1996-04-25	1997-11-11	Mitsubishi Electric Corp	半導体集積回路
JPH1059954A (ja)	1996-08-14	1998-03-03	Takeda Chem Ind Ltd	環状アミン誘導体およびそれを含んでなる医薬
US5869479A (en)	1997-08-14	1999-02-09	Schering Corporation	Treatment of upper airway allergic responses
US6596706B1 (en)	1997-11-07	2003-07-22	Daiichi Pharmaceutical Co., Ltd.	Piperazine-cyclodextrin complexes
GB9803536D0 (en)	1998-02-19	1998-04-15	Black James Foundation	Histamine H,receptor ligands
EP0978512A1 (en) *	1998-07-29	2000-02-09	Societe Civile Bioprojet	Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications
CZ2003686A3 (cs)	2000-08-08	2003-08-13	Ortho Mcneil Pharmaceutical, Inc.	Neimidazolové aryloxypiperidiny
CA2418369A1 (en)	2000-08-08	2002-02-14	Richard Apodaca	Non-imidazole aryloxyalkylamines as h3 receptor ligands
EP1326863A2 (en)	2000-09-22	2003-07-16	Ortho-McNeil Pharmaceutical, Inc.	Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
JP2004532834A (ja)	2001-03-23	2004-10-28	イーライ・リリー・アンド・カンパニー	ヒスタミンｈ３受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用
WO2003004480A2 (en)	2001-07-02	2003-01-16	Novo Nordisk A/S	Substituted piperazine and diazepanes as histamine h3 receptor agonists
JP4619655B2 (ja)	2001-09-14	2011-01-26	ハイ・ポイント・ファーマスーティカルズ、エルエルシー	新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体
EP1434765B1 (en)	2001-09-14	2009-12-02	High Point Pharmaceuticals, LLC	Substituted piperidines with selective binding to histamine h3-receptor
WO2003031432A1 (en)	2001-10-12	2003-04-17	Novo Nordisk A/S	Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
WO2003050099A1 (en)	2001-12-10	2003-06-19	Ortho-Mcneil Pharmaceutical, Inc.	Phenylalkynes
WO2003055866A1 (en)	2001-12-21	2003-07-10	Bayer Pharmaceuticals Corporation	Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
DE10201240A1 (de) *	2002-01-15	2003-07-24	Bayer Ag	Substituierte Alkyluracile und ihre Verwendung
WO2003064411A1 (en)	2002-02-01	2003-08-07	Novo Nordisk A/S	Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
ATE449766T1 (de)	2002-10-23	2009-12-15	Janssen Pharmaceutica Nv	Piperazinyl- und diazapanylbenzamide und- benzothioamide
WO2005035534A1 (ja)	2003-10-08	2005-04-21	Ono Pharmaceutical Co., Ltd.	複素ビシクロ環および複素トリシクロ環化合物およびその医薬
GB0324159D0 (en)	2003-10-15	2003-11-19	Glaxo Group Ltd	Novel compounds

2003
- 2003-10-21 AT AT03809596T patent/ATE449766T1/de active
- 2003-10-21 JP JP2004546967A patent/JP4596918B2/ja not_active Expired - Fee Related
- 2003-10-21 WO PCT/US2003/033343 patent/WO2004037801A1/en not_active Ceased
- 2003-10-21 BR BRPI0315644A patent/BRPI0315644B8/pt not_active IP Right Cessation
- 2003-10-21 NZ NZ576432A patent/NZ576432A/en not_active IP Right Cessation
- 2003-10-21 CA CA2504269A patent/CA2504269C/en not_active Expired - Lifetime
- 2003-10-21 ME MEP-2008-495A patent/ME00334B/me unknown
- 2003-10-21 CN CNB2003801070529A patent/CN100558718C/zh not_active Expired - Fee Related
- 2003-10-21 ES ES03809596T patent/ES2335584T3/es not_active Expired - Lifetime
- 2003-10-21 UA UAA200504801A patent/UA80573C2/uk unknown
- 2003-10-21 PL PL376324A patent/PL215454B1/pl unknown
- 2003-10-21 DE DE60330269T patent/DE60330269D1/de not_active Expired - Lifetime
- 2003-10-21 PT PT03809596T patent/PT1558595E/pt unknown
- 2003-10-21 AU AU2003301552A patent/AU2003301552B2/en not_active Ceased
- 2003-10-21 HR HRP20050352AA patent/HRP20050352B1/hr not_active IP Right Cessation
- 2003-10-21 EP EP03809596A patent/EP1558595B1/en not_active Expired - Lifetime
- 2003-10-21 NZ NZ539595A patent/NZ539595A/en not_active IP Right Cessation
- 2003-10-21 EA EA200500528A patent/EA009860B1/ru unknown
- 2003-10-21 SI SI200331757T patent/SI1558595T1/sl unknown
- 2003-10-21 KR KR1020057006864A patent/KR101067732B1/ko not_active Expired - Fee Related
- 2003-10-21 RS YU20050317A patent/RS51681B/sr unknown
- 2003-10-21 MX MX2009006222A patent/MX339074B/es unknown
- 2003-10-21 MX MXPA05004384A patent/MXPA05004384A/es active IP Right Grant
- 2003-10-21 DK DK03809596.4T patent/DK1558595T3/da active
- 2003-10-21 US US10/690,115 patent/US7414047B2/en not_active Expired - Lifetime
- 2003-10-22 AR ARP030103848A patent/AR041697A1/es active IP Right Grant
- 2003-10-22 MY MYPI20034029A patent/MY140886A/en unknown
- 2003-10-23 TW TW092129372A patent/TWI352594B/zh not_active IP Right Cessation
2005
- 2005-04-20 EG EGNA2005000151 patent/EG25097A/xx active
- 2005-04-21 IL IL168207A patent/IL168207A/en active IP Right Grant
- 2005-04-22 CR CR7807A patent/CR7807A/es not_active Application Discontinuation
- 2005-05-10 NO NO20052278A patent/NO330741B1/no not_active IP Right Cessation
- 2005-05-19 ZA ZA200504067A patent/ZA200504067B/en unknown
2007
- 2007-10-30 US US11/928,006 patent/US20080056991A1/en not_active Abandoned
2010
- 2010-01-15 CY CY20101100040T patent/CY1109924T1/el unknown

Also Published As

Publication number	Publication date
ES2335584T3 (es)	2010-03-30
CY1109924T1 (el)	2014-09-10
ZA200504067B (en)	2006-08-30
US20080056991A1 (en)	2008-03-06
MEP49508A (me)	2011-02-10
DE60330269D1 (de)	2010-01-07
CN1729180A (zh)	2006-02-01
TW200418476A (en)	2004-10-01
US7414047B2 (en)	2008-08-19
CR7807A (es)	2008-09-10
US20040110746A1 (en)	2004-06-10
BRPI0315644B1 (pt)	2018-11-13
EP1558595A1 (en)	2005-08-03
HK1086827A1 (zh)	2006-09-29
BR0315644A (pt)	2005-08-30
TWI352594B (en)	2011-11-21
JP2006510609A (ja)	2006-03-30
AR041697A1 (es)	2005-05-26
CA2504269A1 (en)	2004-05-06
EP1558595B1 (en)	2009-11-25
NO20052278L (no)	2005-06-06
IL168207A (en)	2011-07-31
PL376324A1 (en)	2005-12-27
ATE449766T1 (de)	2009-12-15
KR20050055775A (ko)	2005-06-13
NZ576432A (en)	2010-06-25
HRP20050352B1 (hr)	2013-09-30
AU2003301552A1 (en)	2004-05-13
BRPI0315644B8 (pt)	2021-05-25
DK1558595T3 (da)	2010-03-29
SI1558595T1 (sl)	2010-03-31
RS51681B (sr)	2011-10-31
MXPA05004384A (es)	2005-10-18
NZ539595A (en)	2008-02-29
CN100558718C (zh)	2009-11-11
PL215454B1 (pl)	2013-12-31
ME00334B (me)	2011-05-10
AU2003301552B2 (en)	2010-04-22
HRP20050352A2 (en)	2006-06-30
MX339074B (es)	2016-05-09
NO330741B1 (no)	2011-06-27
MY140886A (en)	2010-01-29
PT1558595E (pt)	2010-01-15
KR101067732B1 (ko)	2011-09-28
EA200500528A1 (ru)	2005-10-27
EA009860B1 (ru)	2008-04-28
RS20050317A (sr)	2007-09-21
UA80573C2 (en)	2007-10-10
JP4596918B2 (ja)	2010-12-15
CA2504269C (en)	2012-01-17
WO2004037801A1 (en)	2004-05-06

Publication	Publication Date	Title
EP1539941A4 (en)	2006-11-29	ADZYMES AND THEIR USES
ZA200603882B (en)	2010-03-31	Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
MXPA03001050A (es)	2003-08-08	Dispositivo desacelerador de rotacion y utilizacion del mismo.
IL175491A0 (en)	2009-02-11	Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
GB0206048D0 (en)	2002-04-24	Use
GB0227666D0 (en)	2003-01-08	Use
AU2003300017A8 (en)	2004-07-29	Microprocessor and microprocessor operation
SI1551805T1 (sl)	2013-07-31	Substituirani gama-fenil-delta-laktami in njihova uporaba
AU2003296369A8 (en)	2004-06-30	Imminoamines and preparation thereof
GB0217056D0 (en)	2002-08-28	Use
ZA200210316B (en)	2003-07-04	Composition and its therapeutic use.
GB0213878D0 (en)	2002-07-31	Use
AU2003298129A8 (en)	2004-06-15	Floor-furnace chimney and the use thereof
IL165112A0 (en)	2005-12-18	Variant integrinpolypeptides and thereof
AU2003231827A8 (en)	2003-12-12	Pseudo-tissues and uses thereof
ZA200307846B (en)	2004-07-06	Latex and its preparation.
AU2003302173A8 (en)	2004-07-14	Spirotetrathiocarbamates and spirooxothiocarbamates
GB0206838D0 (en)	2002-05-01	Use
EP1487547A4 (en)	2010-09-15	MEDIUM FOR PHYSICAL INTERACTION AND ITS RELATED USES
AU2003228397A8 (en)	2003-10-20	Hausp-p53 interaction and uses thereof
GB0207624D0 (en)	2002-05-15	Chemokine and uses thereof
GB0230343D0 (en)	2003-02-05	Use
GB0312340D0 (en)	2003-07-02	Improved game and aricle for use with the game
AU2003216442A8 (en)	2003-09-09	Enkurin and uses thereof
MXPA02005784A (es)	2003-12-16	Cepillo de dientes, estruche-mango para el mismo y soporte para dicho cepillo de dientes.